The future of the global interventional cardiology and peripheral vascular device market looks good with opportunities in hospitals and ambulatory surgical centers. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $38.3 billion by 2030, and it is forecast to grow at a CAGR of 5.6% from 2024 to 2030. The major drivers are growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
The global interventional cardiology and peripheral vascular device market is projected to reach $38.3 billion by 2030, at a CAGR of 5.6% during 2024-2030. The growth of interventional cardiology and peripheral vascular device market is driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the most promising, high-growth opportunities for the interventional cardiology and peripheral vascular device market by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 What are the business risks and threats to the interventional cardiology and peripheral vascular device market?
Q.4 What are some changing demands of customers in the interventional cardiology and peripheral vascular device market?
Q.5 What are the new developments in the interventional cardiology and peripheral vascular device market? Which companies are leading these developments?
Q.6 What strategic initiatives are being implemented by key players for business growth?
Q.7 What are some of the competitive products and processes in this interventional cardiology and peripheral vascular device area and how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this interventional cardiology and peripheral vascular device market?
Market Segmentation:
Based on type, the interventional cardiology and peripheral vascular device market is segmented into interventional cardiology and peripheral vascular device. The interventional cardiology segment accounted for the largest share of the market in 2024 and is expected to register the highest CAGR during the forecast period, because of new technology innovations and aging population.
Asia Pacific is expected to be the largest region with the highest growth over the forecast period due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.
Key Players in the interventional cardiology and peripheral vascular device market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, Cardinal Health Inc.
The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries.
Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Explore Our Latest Publications
Healthcare Big Data Analytic Market
Liver Health Supplement Market
Medical Scrub Market
C Reactive Protein Testing Market
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email
Phone: 9728048283
Address:LUCINTEL, 8951 Cypress Waters Blvd., Suite 160 Suite 160
City: Dallas
State: Texas
Country: United States
Website: https://www.lucintel.com/
